N
Nuvectis Pharma, Inc.
NVCT · NASDAQ · Healthcare · 503M
Closing price
$21.12
+4.92% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
25.0×
Enterprise value / EBITDAEV/EBITDA
-16.2×
Free cash flow yieldFCF yield
-3.5%
Return on equityROE
-143.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.